Trials / Sponsors / Zhejiang Teruisi Pharmaceutical Inc.
Zhejiang Teruisi Pharmaceutical Inc.
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previ Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 1 / Phase 2 | 2025-09-01 |
| Not Yet Recruiting | A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL. CD20-positive Diffuse Large B-Cell Lymphoma | Phase 2 | 2025-09-01 |
| Unknown | A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC Metastatic Colorectal Cancer (CRC) | Phase 3 | 2022-08-01 |
| Active Not Recruiting | A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL. CD20-positive B-cell Non-Hodgkin Lymphoma | Phase 1 | 2020-09-08 |
| Unknown | A Study to Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSC Advanced Non-squamous Non-small-cell Lung Cancer | Phase 3 | 2020-08-17 |
| Completed | A Study to Compare Pharmacokinetic and Safety of TRS003 to China-approved Bevacizumab and US-licensed Avastin® Healthy | Phase 1 | 2018-06-12 |